Molecular mechanisms of mitochondrial DNA depletion diseases caused by deficiencies in enzymes in purine and pyrimidine metabolism

Nucleosides, Nucleotides and Nucleic Acids

Volumn 27, Issue 6-7, 2008, Pages 800-808

  Eriksson, Staffan ^a   Wang, Liya ^a  

^a SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

Author keywords

Deoxyguanosine kinase; Mitochondrial DNA depletion syndrome; MtDNA synthesis; Thymidine kinase2

Indexed keywords

DEOXYGUANOSINE KINASE; DEOXYRIBONUCLEOTIDE; PURINE; PYRIMIDINE; THYMIDINE KINASE; THYMIDINE KINASE 2;

ANIMAL TISSUE; CONFERENCE PAPER; DNA REPLICATION; ENZYME DEFICIENCY; ENZYME METABOLISM; GENE MUTATION; MITOCHONDRIAL DNA DEPLETION; MITOCHONDRIAL DNA DEPLETION SYNDROME; MOUSE; MUSCLE; NONHUMAN; PROTEIN EXPRESSION; SPLEEN;

ANIMALS; DNA, MITOCHONDRIAL; ENZYMES; HUMANS; MITOCHONDRIAL DISEASES; NUCLEIC ACID PRECURSORS; PURINES; PYRIMIDINES;

EID: 46749135572     PISSN: 15257770     EISSN: 15322335     Source Type: Journal    
DOI: 10.1080/15257770802146197     Document Type: Conference Paper

References (30)

1. Moraes, C.T.; Shanske, S.; Tritschler, H.J.; Aprille, J.R.; Andreetta, F.; Bonilla, E.; Schon, E.A.; DiMauro, S. mtDNA depletion with variable tissue expression: A novel genetic abnormality in mitochondrial diseases. Am. J. Hum. Genet. 1991, 48, 492-501.
2. DiMauro, S.; Schon, E.A. Mitochondrial respiratory-chain diseases. N. Engl. J. Med. 2003, 348, 2656-2668.
3. Elpeleg, O. Inherited mitochondrial DNA depletion. Pediatr. Res. 2003, 54, 153-159.
4. Sarzi, E.; Bourdon, A.; Chretien, D.; Zarhrate, M.; Corcos, J.; Slama, A.; Cormier-Daire, V.; de Lonlay, P.; Munnich, A.; Rotig, A. Mitochondrial DNA depletion is a prevalent cause of multiple respiratory chain deficiency in childhood. J. Pediatr. 2007, 150, 531-534.
5. Nishino, I.; Spinazzola, A.; Hirano, M. Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder. Science 1999, 283, 689-692.
6. Pontarin, G.; Ferraro, P.; Håkansson, P.; Thelander, L.; Reichard, P.; Bianchi, V. p53R2-dependent ribonucleotide reduction provides deoxyribonucleotides in quiescent human fibroblasts in the absence of induced DNA damage. J. Biol. Chem. 2007, 282, 16820-16828.
7. Eriksson, S.; Munch-Petersen, B.; Johansson, K.; Eklund, H. Structure and function of cellular deoxyribonucleoside kinases. Cell Mol. Life Sci. 2002, 59, 1327-1346.
8. Bianchi, V.; Spychala, J. Mammalian 5′-nucleotidases. J. Biol. Chem. 2003, 278, 46195-46198.
9. Bourdon, A.; Minai, L.; Serre, V.; Jais, J.P.; Sarzi, E.; Aubert, S.; Chretien, D.; de Lonlay, P.; Paquis-Flucklinger, V.; Arakawa, H.; Nakamura, Y.; Munnich, A.; Rotig, A. Mutation of RRM2B, encoding p53-controlled ribonucleotide reductase (p53R2), causes severemitochondrial DNA depletion. Nat. Genet. 2007, 39, 776-780.
10. Thelander L. Ribonucleotide reductase and mitochondrial DNA synthesis. Nat. Genet. 2007, 39, 703-704.
11. Lam, W.; Chen, C.; Ruan, S.; Leung, C.H.; Cheng, Y.C. Expression of deoxynucleotide carrier is not associated with the mitochondrial DNA depletion caused by anti-HIV dideoxynucleoside analogs and mitochondrial dNTP uptake. Mol. Pharmacol. 2005, 67, 408-416.
12. Nishigaki, Y.; Marti, R.; Copeland, W.C.; Hirano, M. Site-specific somatic mitochondrial DNA point mutations in patients with thymidine phosphorylase deficiency. J. Clin. Invest. 2003, 111, 1913-1921.
13. Naviaux, R.K.; Nguyen, K.V. POLG mutations associated with Alpers syndrome and mitochondrial DNA depletion. Ann. Neurol. 2005, 55, 706-712.
14. Nguyen, K.V.; Ostergaard, E.; Ravn, S.H.; Balslev, T.; Danielsen, E.R.; Vardag, A.; McKiernan, P.J.; Gray, G.; Naviaux R.K. POLG mutations in Alpers syndrome. Neurology 2005, 65, 1493-1495.
15. Elpeleg, O.; Miller, C.; Hershkovitz, E.; Bitner-Glindzicz, M.; Bondi-Rubinstein, G.; Rahman, S.; Pagnamenta, A.; Eshhar, S.; Saada, A. Deficiency of the ADP-forming succinyl-CoA synthase activity is associated with encephalomyopathy and mitochondrial DNA depletion. Am. J. Hum. Genet. 2005, 76, 1081-1086.
16. Spinazzola, A.; Viscomi, C.; Fernandez-Vizarra, E.; Carrara, F.; D'Adamo, P.; Calvo, S.; Marsano, R.M.; Donnini, C.; Weiher, H.; Strisciuglio, P.; Parini, R.; Sarzi, E.; Chan, A.; DiMauro, S.; Rotig, A.; Gasparini, P.; Ferrero, I.; Mootha, V.K.; Tiranti, V.; Zeviani, M. MPV17 encodes an inner mitochondrial membrane protein and is mutated in infantile hepatic mitochondrial DNA depletion. Nat. Genet. 2006, 38, 570-575.
17. Johansson, K.; Ramaswamy, S.; Ljungcrantz, C.; Knecht, W.; Piskur, J.; Munch-Petersen, B.; Eriksson, S.; Eklund, H. Structural basis for substrate specificities of cellular deoxyribonucleoside kinases. Nat. Struct. Biol. 2001, 8, 616-620.
18. Johansson, M.; Karlsson, A. Cloning of the cDNA and chromosome localization of the gene for human thymidine kinase 2. J. Biol. Chem. 1997, 272, 8454-8458.
19. Wang, L.; Munch-Petersen, B.; Herrström Sjöberg, A.; Hellman, U.; Bergman, T.; Jörnvall, H.; Eriksson, S. Human thymidine kinase 2: molecular cloning and characterisation of the enzyme activity with antiviral and cytostatic nucleoside substrates. FEBS Lett. 1999, 443, 170-174.
20. Wang, L.; Eriksson, S. Cloning and characterization of full-length mouse thymidine kinase 2: the N-terminal sequence directs import of the precursor protein into mitochondria. Biochem. J. 2000, 351, 469-476.
21. Galbiati, S.; Bordoni, A.; Papadimitriou, D.; Toscano, A.; Rodolico, C.; Katsarou, E.; Sciacco, M.; Garufi, A.; Prelle, A.; Aguennouz, M.; Bonsignore, M.; Crimi, M.; Martinuzzi, A.; Bresolin, N.; Papadimitriou, A.; Comi G.P. New mutations in TK2 gene associated with mitochondrial DNA depletion. Pediatr. Neurol. 2006, 34, 177-185.
22. Oskoui, M.; Davidzon, G.; Pascual, J.; Erazo, R.; Gurgel-Giannetti, J.; Krishna, S.; Bonilla, E.; De Vivo, D.C.; Shanske, S.; DiMauro, S. Clinical spectrum of mitochondrial DNA depletion due to mutations in the thymidine kinase 2 gene. Arch. Neurol. 2006, 63, 1122-1126.
23. Saada, A.; Shaag, A.; Mandel, H.; Nevo, Y.; Eriksson, S.; Elpeleg, O.Mutantmitochondrial thymidine kinase in mitochondrial DNA depletion myopathy. Nat. Genet. 2001, 29, 342-344.
24. Mandel, H.; Szargel, R.; Labay, V.; Elpeleg, O.; Saada, A.; Shalata, A., Anbinder, Y.; Berkowitz, D.; Hartman, C.; Barak, M.; Eriksson, S.; Cohen, N. The deoxyguanosine kinase gene is mutated in individuals with depleted hepatocerebral mitochondrial DNA. Nat. Genet. 2001, 29, 337-341.
25. Wang, L.; Saada, A.; Eriksson S. Kinetic properties of mutant human thymidine kinase 2 suggest a mechanism for mitochondrial DNA depletion myopathy. J. Biol. Chem. 2003, 278, 6963-6968.
26. Wang, L.; Eriksson, S. Mitochondrial deoxyguanosine kinase mutations and mitochondrial DNA depletion syndrome. FEBS Lett. 2003, 554, 319-322.
27. Wang, L.; Limongelli, A.; Vila, M.R.; Carrara, F.; Zeviani, M.; Eriksson, S. Molecular insight into mitochondrial DNA depletion syndrome in two patients with novel mutations in the deoxyguanosine kinase and thymidine kinase 2 genes. Mol. Genet. Metab. 2005, 84, 75-82.
28. Freisinger, P.; Futterer, N.; Lankes, E.; Gempel, K.; Berger, T.M.; Spalinger, J.; Hoerbe, A.; Schwantes, C.; Lindner, M.; Santer, R.; Burdelski, M.; Schaefer, H.; Setzer, B.; Walker, U.A.; Horvath, R. Hepatocerebral mitochondrial DNA depletion syndrome caused by deoxyguanosine kinase (DGUOK) mutations Arch. Neurol. 2006, 63, 1129-1134.
29. Mousson de Camaret, B.; Taanman, J.W.; Padet, S.; Chassagne, M.; Mayencon, M.; Clerc-Renaud, P.; Mandon, G.; Zabot, M.T.; Lachaux, A.; Bozon, D. Kinetic properties of mutant deoxyguanosine kinase in a case of reversible hepatic mtDNA depletion. Biochem. J. 2007, 402, 377-385.
30. Rylova, S.N.; Mirzaee, S.; Albertioni, F.; Eriksson, S. Expression of deoxynucleoside kinases and 5′-nucleotidases in mouse tissues: Implications for mitochondrial toxicity. Biochem. Pharmacol. 2007, 74, 169-175.